Predictive value of neutrophil to lymphocyte ratio for the presence of coronary artery ectasia in patients with aortic aneurysms  by Ikenaga, Hiroki et al.
IJC Heart & Vessels 4 (2014) 30–34
Contents lists available at ScienceDirect
IJC Heart & Vessels
j ou rna l homepage: ht tp : / /www. journa ls .e lsev ie r .com/ i j c -hear t -and-vesse lsPredictive value of neutrophil to lymphocyte ratio for the presence of
coronary artery ectasia in patients with aortic aneurysmsHiroki Ikenaga a, Satoshi Kurisu a,⁎, Noriaki Watanabe a, Takashi Shimonaga a, Tadanao Higaki a,
Toshitaka Iwasaki a, Hiroto Utsunomiya a, NaoyaMitsuba a, Ken Ishibashi a, Yoshihiro Dohi a, Yukihiro Fukuda a,
Katsuhiko Imai b, Taijiro Sueda b, Yasuki Kihara a
a Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan
b Department of Cardiovascular Surgery, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan⁎ Corresponding author at: Department of Cardiov
University Graduate School of Biomedical and Hea
Minami-ku, Hiroshima 734-8551, Japan. Tel./fax: +81 82
E-mail address: skurisu@nifty.com (S. Kurisu).
http://dx.doi.org/10.1016/j.ijchv.2014.08.002
2214-7632/© 2014 The Authors. Published by Elsevier Irea b s t r a c ta r t i c l e i n f oArticle history:
Received 27 May 2014
Received in revised form 5 August 2014
Accepted 10 August 2014
Available online 15 August 2014
Keywords:
Coronary artery ectasia
Aortic aneurysms
Neutrophil to lymphocyte ratio
Background: Both aortic aneurysms and coronary artery ectasia (CAE) frequently coexist and are associated with
more pronounced inﬂammation. Neutrophil to lymphocyte ratio (NL ratio) is widely used as a marker of inﬂam-
mation. However, relation between CAE and NL ratio in patients with aortic aneurysms is not fully understood.
This study was undertaken to assess relation between CAE and NL ratio in patients with aortic aneurysms.
Methods: This study consisted of 93 consecutive patients with aortic aneurysms (AA group) and 79 patients
without aortic aneurysms who had angiographically normal coronary arteries as the control group. Moreover,
patients with aortic aneurysms were classiﬁed into two groups based on the presence of CAE; CAE (+) group
(n = 44) and CAE (−) group (n = 49). We compared blood chemical parameters in both groups.
Results: In the AA group, 44 patients (47.3%) had CAE. The AA group had a signiﬁcantly higher NL ratio than the
control group (2.93 ± 1.43 vs. 2.45 ± 1.05, p = 0.027). Furthermore, the CAE (+) group had a signiﬁcantly
higher NL ratio than the CAE (−) group (3.39 ± 1.67 vs. 2.52 ± 1.04, p b 0.01). Multivariate logistic regression
analysis revealed that the high NL ratio was an independent predictor for CAE in patients with aortic aneurysms
(odds ratio 1.76, 95% conﬁdence interval 1.24–2.69, p = 0.001).
Conclusions: Patients with aortic aneurysms had a signiﬁcantly higher NL ratio than those without aortic aneu-
rysms. Furthermore, the NL ratio might predict the presence of CAE in patients with aortic aneurysms.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Aortic aneurysms are an important cardiovascular disease and a
complex disease with both genetic and environmental factors
contributing to the disease process. In practice, established risk factors
for aortic aneurysms include advancing age, male gender, smoking,
hypertension and atherosclerosis [1]. In addition, aortic aneurysms are
associated with more pronounced inﬂammation and elevation of in-
ﬂammatory markers in patients with aortic aneurysms is widely recog-
nized [2]. Also, coronary artery disease is the most important cause of
morbidity and mortality in patients with aortic aneurysms, including
during the postoperative period of aortic aneurysms [3]. However, it is
difﬁcult to predict morbidity and mortality only by evaluating coronary
artery stenosis [4]. On the other hand, it was reported that coronary
artery ectasia (CAE) was frequently observed in patients with aorticascular Medicine, Hiroshima
lth Sciences, 1-2-3 Kasumi,
257 1602.
land Ltd. This is an open access articlaneurysms [5,6] and CAE regardless of aortic aneurysms may be a
form of atherosclerosis with more active inﬂammatory [7–11]. White
blood cell (WBC) count and related parameters are markers of inﬂam-
mation in cardiovascular disease [12,13]. Especially, neutrophil to
lymphocyte ratio (NL ratio) has been shown to have the greatest predic-
tive value for poor outcomes in patients with coronary artery disease
[13]. However, the relation between CAE and NL ratio in patients with
aortic aneurysms is not fully understood. This study was undertaken
to assess the relation between CAE and NL ratio in patients with aortic
aneurysms.
2. Methods
2.1. Study patient
In total, 1735 patients underwent coronary angiograms from
January 2011 to October 2013 at Hiroshima University Graduate School
of Biomedical and Health Sciences. Of these, we excluded patients
accompanied with acute coronary syndrome and chronic inﬂamma-
tory disease. In addition, we excluded patients with traumatic,e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Baseline characteristics between the patients with AA and those without AA.
AA group
(n = 93)
Control group
(n = 79)
p value
Clinical characteristics
Age (years) 72.8 ± 8.8 67.1 ± 10.9 b0.001
Male 75 (80.7%) 55 (69.6%) 0.09
Hypertension 77 (82.8%) 55 (69.6%) 0.04
Dyslipidemia 41 (44.1%) 41 (51.9%) 0.31
Diabetes mellitus 17 (18.3%) 28 (35.4%) 0.01
Current smoker 28 (30.1%) 23 (29.1%) 0.87
Body mass index (kg/m2) 23.4 ± 4.0 24.1 ± 3.7 0.28
Previous MI 6 (6.5%) 0 (0%) 0.02
Atrial ﬁbrillation 9 (9.7%) 5 (6.3%) 0.42
Medication
Aspirin 28 (30.1%) 19 (24.1%) 0.37
β-Blocker 28 (30.1%) 16 (20.3%) 0.13
Ca-blocker 51 (54.8%) 41 (51.9%) 0.70
ACE-I/ARB 56 (60.2%) 36 (45.6%) 0.06
Statin 28 (30.1%) 23 (29.1%) 0.43
Diuretic 11 (11.8%) 12 (15.2%) 0.52
LVEF (%) 60.4 ± 7.8 61.7 ± 7.2 0.16
Laboratory data
White blood cell (103/μl) 6721 ± 2258 6396 ± 2121 0.30
NL ratio 2.93 ± 1.43 2.45 ± 1.05 0.027
Hemoglobin (g/dl) 12.95 ± 2.07 13.42 ± 1.90 0.11
Hematocrit (%) 38.33 ± 5.70 39.58 ± 5.11 0.13
C-reactive protein (mg/dl) 1.03 ± 2.97 0.19 ± 0.29 b0.01
Platelet (mm3/μl) 187.30 ± 62.26 200.29 ± 66.37 0.48
eGFR (ml/min per 1.73 m2) 61.02 ± 22.78 65.80 ± 28.74 0.08
eGFR b 60 ml/min per 1.73 m2 41 (44.1%) 28 (35.4%) 0.25
HDL cholesterol (mg/dl) 50.9 ± 14.3 57.6 ± 22.1 0.054
LDL cholesterol (mg/dl) 110.4 ± 28.9 110.1 ± 44.1 0.40
Triglyceride (mg/dl) 133.9 ± 64.1 147.2 ± 127.9 0.78
HbA1c (%) 5.92 ± 0.52 6.24 ± 1.45 0.63
D-dimer (μg/ml) 6.73 ± 7.67 1.03 ± 1.59 b0.01
MI; myocardial infarction, ACE-I; angiotensin-converting enzyme inhibitor, ARB; angio-
tensin II receptor blocker, LVEF; left ventricular ejection fraction, NL ratio; neutrophil
to lymphocyte ratio, eGFR; estimated glomerular ﬁltration rate, HDL; high-density
lipoprotein, LDL; low-density lipoprotein, HbA1c; hemoglobin A1c. P values were two-
tailed, and p b 0.05 was considered as statistically signiﬁcant.
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retrospectively analyzed 93 consecutive patients with aortic aneu-
rysms (AA group) and 79 patients without aortic aneurysms who
had angiographically normal coronary arteries and no ischemia on
myocardial perfusion scintigram or the treadmill exercise test as
the control group (control group). Moreover, patients with aortic an-
eurysms were classiﬁed into two groups based on the presence of
CAE; CAE (+) group (n= 44) and CAE (−) group (n= 49). Coronary
angiograms were performed due to the presence of anginal chest
pain or the evaluation of coronary artery before aortic aneurysm sur-
gery. Angiographically normal coronary arteries were deﬁned as no
reduction of the internal diameter of the coronary arteries. Aortic an-
eurysms were deﬁned as a circumferential or local enlargement (the
diameter was increased to a degree at least 1.5-fold greater than nor-
mal (exceeding 45 mm in the thoracic region and 30 mm in the ab-
dominal region)) or protrusion of a part of the aortic wall [14,15].
The maximum minor-axis diameter was used in principle for plain
and early contrast-enhanced computed tomography images [16]. Es-
timated glomerular ﬁltration rate (eGFR) was calculated using the
Japanese equations from serum creatinine, and chronic kidney dis-
ease (CKD) was thought to be present if it was b60 ml/min per
1.73 m2. Informed consent was obtained from each patient. This
study was approved by the ethical committee at Hiroshima Universi-
ty Graduate School of Biomedical and Health Sciences.
2.2. Laboratory measurements
Blood samples were collected from the ante-cubital vein by an
atraumatic puncture just before the coronary angiography in the
postabsorptive state and were sent to the central laboratory of our
hospital within 1 h after collection. Venous blood was collected in a
tube containing K3 EDTA for the measurement of hematologic indices
in all patients. Hematologic indices were evaluated from a complete
blood count analysis performed at the central laboratory of our hospital.
2.3. Angiographic evaluation
Coronary angiograms were obtained and evaluated according to
standard techniques using 4 Fr catheter. Usingquantitative coronary an-
giographic (QCA) analysis (QCA-CMS v.6.0,Medis, Leiden, NL), coronary
artery stenosis was deﬁned as the 50% reduction of the internal diame-
ter of the coronary arteries compared to normal, non-ectatic segments.
Coronary artery disease (CAD) severity was assessed by the number of
diseased vessels [the right coronary artery (RCA), left anterior descend-
ing (LAD), or left circumﬂex (LCX) coronary artery]. The left main
coronary artery (LMCA) was considered a two-vessel disease. Coronary
artery ectasia (CAE)was deﬁned as coronary arterywith the diameter of
the ectatic segment being more than 1.5-fold larger compared with an
adjacent healthy reference segment [17,18].
2.4. Statistical analysis
Standard statistical methods were used in this study. Signiﬁcant dif-
ferenceswere tested using the χ2 test for categorical variables. Normally
distributed continuous variables were presented as mean and standard
deviation (SD). Unpaired Student's t test or Wilcoxon rank-sum test
when appropriate was used for continuous variables. Univariate
andmultivariate logistic regression analyses were used to identify inde-
pendent predictors of the presence of CAE in patients with aortic aneu-
rysms, adjusting blood chemical parameters. The univariable predictors
with a p value of less than 0.1were entered into amultivariatemodel. In
addition, to adjust for selection bias, propensity scores for each patient
were estimated with logistic regression, with CAE (+) as the outcome.
Eighteen baseline clinical variableswere chosen for imputation and der-
ivation of propensity scores, based on clinical relevance and ability to
correct for differences between CAE (+) and CAE (−) groups. TheJMP statistical package (version 11.0, SAS Institute, Inc. Cary, NC, USA)
was used for all statistical tests. A signiﬁcance level of 0.05 was used
and two-tailed tests were applied.
3. Results
In the AA group, there were 30 (32.3%) patients with ascending tho-
racic aneurysms and 63 (67.7%) patients with descending thoracic or
abdominal aneurysms. The baseline characteristics of the study patients
are shown in Table 1. Age, the frequencies of hypertension and previous
myocardial infarction (MI) were signiﬁcantly higher in the AA group
than in the control group (age; 72.8 ± 8.8 years vs. 67.1 ± 10.9 years,
p b 0.001, hypertension; 82.8% vs. 69.6%, p = 0.04, previous MI; 6.5%
vs. 0%, p = 0.02, respectively). The frequencies of diabetes mellitus was
signiﬁcantly lower in the AA group than in the control group (18.3% vs.
35.4%, p = 0.01). There was no signiﬁcant difference in other baseline
clinical variables between the AA group and the control group. The AA
group had a signiﬁcantly higher C-reactive protein level and D-dimer
level than the control group (C-reactive protein; 1.03 ± 2.97 mg/dl vs.
0.19 ± 0.29 mg/dl, p b 0.01, D-dimer; 6.73 ± 7.67 μg/ml vs. 1.03 ±
1.59 μg/ml, p b 0.01, respectively). The AA group had a signiﬁcantly
higher NL ratio than the control group (2.93 ± 1.43 vs. 2.45 ± 1.05,
p = 0.027). There was no signiﬁcant difference in other blood chemical
parameters between the AA group and the control group.
Angiographic characteristics of the study patients are shown in
Table 2. Forty-three of 93 patients (46.2%) in the AA group had a signif-
icant coronary artery stenosis. In the AA group, the prevalence of coro-
nary artery stenosis and CAD severity were signiﬁcantly higher in the
patients with descending thoracic or abdominal aneurysms than those
Table 2
Angiographic characteristics between the patients with AA and those without AA.
AA group
(n = 93)
Control group
(n = 79)
Coronary stenosis 43 (46.2%) –
LMCA stenosis 8 (8.6%) –
LAD stenosis 16 (17.2%) –
LCX stenosis 13 (14.0%) –
RCA stenosis 26 (28.0%) –
CAD severity
1-Vessel disease 25 (26.9%) –
2-Vessel disease 11 (11.9%) –
3-Vessel disease 7 (7.5%) –
Coronary ectasia 44 (47.3%) –
LAD ectasia 30 (32.6%) –
Diffuse 17 (18.5%) –
LCX ectasia 24 (26.1%) –
Diffuse 21 (22.8%) –
RCA ectasia 32 (34.8%) –
Diffuse 29 (31.5%) –
LMCA = left main coronary artery, LAD = left anterior descending coronary artery,
LCX = left circumﬂex coronary artery, RCA = right coronary artery, CAD = coronary
artery disease.
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26.7%, p b 0.01, CAD severity; 1-/2-/3-vessel disease; 30.1/14.3/11.1%
vs. 20.0/6.7/0%, p b 0.02). Forty-four of 93 patients (47.6%) in the AA
group had CAE. The prevalence of CAE in the AA group was 32.6% in
LAD, 26.1% in the LCX and 34.8% in RCA in the AA group. Also, in eachTable 3
Baseline characteristics between the patients with CAE and those without CAE in the AA
group.
CAE (+) group
(n = 44)
CAE (−) group
(n = 49)
p value
Clinical characteristics
Ascending thoracic aneurysms 11 (25.0%) 19 (38.8%) 0.15
Age (years) 72.5 ± 9.8 73.2 ± 8.0 0.92
Male 36 (81.8%) 39 (79.6%) 0.79
Hypertension 39 (88.6%) 38 (77.6%) 0.15
Dyslipidemia 21 (47.7%) 20 (40.8%) 0.50
Diabetes mellitus 7 (15.9%) 10 (20.4%) 0.31
Current smoker 11 (25.0%) 17 (34.7%) 0.87
Body mass index (kg/m2) 23.7 ± 3.7 23.1 ± 3.7 0.50
Previous MI 3 (6.8%) 3 (6.1%) 0.89
Atrial ﬁbrillation 6 (13.6%) 3 (6.1%) 0.22
Medication
Aspirin 15 (34.1%) 13 (26.5%) 0.43
β-Blocker 18 (40.9%) 10 (20.4%) 0.03
Ca-blocker 28 (63.6%) 23 (46.9%) 0.11
ACE-I/ARB 31 (70.5%) 25 (51.0%) 0.06
Statin 24 (54.6%) 18 (36.7%) 0.08
Diuretic 5 (11.4%) 6 (12.2%) 0.90
LVEF (%) 60.0 ± 6.9 60.1 ± 8.6 0.55
Laboratory data
White blood cell (103/μl) 7149 ± 1937 6338 ± 2469 0.04
NL ratio 3.39 ± 1.67 2.52 ± 1.04 b0.01
Hemoglobin (g/dl) 13.25 ± 2.12 12.68 ± 2.00 0.21
Hematocrit (%) 39.27 ± 5.69 37.51 ± 5.65 0.13
C-reactive protein (mg/dl) 1.39 ± 4.01 0.72 ± 1.53 0.99
Platelet (mm3/μl) 197.71 ± 59.91 177.96 ± 63.44 0.12
eGFR (ml/min per 1.73 m2) 60.60 ± 26.83 61.39 ± 18.68 0.94
eGFR b 60 ml/min per 1.73 m2 17 (38.6%) 24 (50.0%) 0.32
HDL cholesterol (mg/dl) 48.4 ± 13.1 53.2 ± 15.1 0.12
LDL cholesterol (mg/dl) 113.9 ± 28.4 107.1 ± 29.4 0.35
Triglyceride (mg/dl) 147.4 ± 61.4 121.7 ± 64.6 0.02
HbA1c (%) 6.02 ± 0.46 5.85 ± 0.57 0.13
D-dimer (μg/ml) 6.10 ± 7.25 7.34 ± 8.12 0.42
MI; myocardial infarction, ACE-I; angiotensin-converting enzyme inhibitor, ARB; angio-
tensin II receptor blocker, LVEF; left ventricular ejection fraction, NL ratio; neutrophil to
lymphocyte ratio, eGFR; estimated glomerular ﬁltration rate, HDL; high-density lipopro-
tein, LDL; low-density lipoprotein, HbA1c; hemoglobin A1c. P values were two-tailed,
and p b 0.05 was considered statistically signiﬁcant.ectatic artery, the prevalence of diffuse CAE was 56.6% in LAD, 87.5% in
LCX and 90.6% in RCA.
The baseline characteristics between the CAE (+) group and the
CAE (−) group are shown in Table 3. Therewas no signiﬁcant difference
in the ratio of ascending thoracic aneurysms. Prescription of β-blocker
was signiﬁcantly higher in the CAE (+) group than in the CAE (−)
group (40.9% vs. 20.4%, p = 0.03). There was no signiﬁcant difference
in other baseline clinical variables between the CAE (+) group and
the CAE (−) group. The CAE (+) group had a signiﬁcantly higher
WBC level and triglyceride level than the CAE (−) group (WBC;
7149 ± 1937103/μl vs. 6338 ± 2469103/μl, p = 0.04, triglyceride;
147.4± 61.4 mg/dl vs. 121.7± 64.6 mg/dl, p= 0.02, respectively). Re-
lation between NL ratio and CAE in patients with aortic aneurysms is
shown in Fig. 1. The CAE (+) group had a signiﬁcantly higher NL ratio
than the CAE (−) group (3.39± 1.67 vs. 2.52± 1.04, p b 0.01). Univar-
iate and multivariate logistic regression analyses to identify indepen-
dent predictors of the presence of CAE in patients with aortic
aneurysms are shown in Table 4. Univariate analysis revealed that the
NL ratio and triglyceride were associated with CAE in patients with
aortic aneurysms (NL ratio; odds ratio [OR] 1.65, 95% conﬁdence inter-
val [CI] 1.18–2.44, p = 0.002, triglyceride; OR 1.01, 95% CI 1.01–1.02,
p = 0.049, respectively). To detect the independent effect of the NL
ratio for the presence of CAE in patients with aortic aneurysms, the NL
ratio as well as triglyceride and high-density lipoprotein cholesterol
was incorporated to multivariate logistic regression analysis. Multivari-
ate logistic regression analysis revealed that the high NL ratio was an
independent predictor for CAE in patients with aortic aneurysms (OR
1.76, 95% CI 1.24–2.69, p = 0.001). Logistic regression analysis of the
NL ratio for CAE after adjustment for propensity scores is shown in
Table 4. After adjusting for ascending thoracic aneurysms, age,male, hy-
pertension, dyslipidemia, diabetes mellitus, current smoker, body mass
index, previous MI, atrial ﬁbrillation, left ventricular ejection fraction,
use of aspirin, β-blocker, Ca-blocker, angiotensin-converting enzyme
inhibitor (ACE-I), angiotensin II receptor blocker (ARB), statin and
diuretic using propensity scores, the NL ratio was an independent pre-
dictor for CAE in patients with aortic aneurysms (OR 1.56, 95% CI
1.10–2.40, p = 0.01).4. Discussion
The major ﬁnding of the present study was that patients with aortic
aneurysms had a signiﬁcantly higher NL ratio than those without aortic
aneurysms. Furthermore, among the AA group, patients with CAE had a
signiﬁcantly higher NL ratio than those without CAE and the high NL
ratio might predict the presence of CAE. To our knowledge, this is theFig. 1. Relation between NL ratio and coronary artery ectasia in patients with aortic
aneurysms. The CAE (+) group had a signiﬁcantly higher NL ratio than the CAE (−)
group (3.39 ± 1.67 vs. 2.52 ± 1.04, p b 0.01). NL ratio; neutrophil to lymphocyte ratio,
CAE; coronary artery ectasia.
Table 4
Independent predictors of coronary artery ectasia in patients with aortic aneurysms.
Univariate
OR 95% CI
p value Multivariate
OR 95% CI
p value
White blood cell (103/μl) 0.99 (0.99–1.01) 0.79
NL ratio 1.65 (1.18–2.44) 0.002 1.76 (1.24–2.69) 0.001
Hemoglobin (g/dl) 1.15 (0.94–1.43) 0.18
Hematocrit (%) 1.06 (0.83–1.15) 0.13
C-reactive protein (mg/dl) 1.09 (0.94–1.37) 0.26
Platelet (mm3/μl) 1.00 (0.99–1.02) 0.12
eGFR (ml/min per
1.73 m2)
0.99 (0.98–1.02) 0.86
eGFR b 60 ml/min per
1.73 m2
1.52 (0.28–1.64) 0.32
HDL cholesterol (mg/dl) 0.98 (0.94–1.01) 0.09 0.99 (0.95–1.02) 0.50
LDL cholesterol (mg/dl) 1.00 (0.99–1.02) 0.26
Triglyceride (mg/dl) 1.01 (1.01–1.02) 0.049 1.00 (0.99–1.01) 0.07
HbA1c (%) 1.91 (0.83–5.01) 0.13
D-dimer (μg/ml) 0.98 (0.92–1.01) 0.49
After adjustment for
propensity scoresa
NL ratio 1.56 (1.10–2.40) 0.01
OR; odds ratio, CI; conﬁdence interval, NL ratio; neutrophil to lymphocyte ratio, eGFR;
estimated glomerular ﬁltration rate, HDL; high-density lipoprotein, LDL; low-density
lipoprotein, HbA1c; hemoglobin A1c.
a Adjusted for ascending thoracic aneurysms, age, male, hypertension, dyslipidemia,
diabetesmellitus, current smoker, bodymass index, previousmyocardial infarction, atrial
ﬁbrillation, left ventricular ejection fraction, use of aspirin, β-blocker, Ca-blocker,
angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker, statin and
diuretic.
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with aortic aneurysms.
Previous studies have shown that there are some differences in the
pathobiology between descending thoracic or abdominal aortic aneu-
rysms and ascending thoracic aneurysms [19,20]. Descending thoracic
or abdominal aortic aneurysms are characterized by a decrease in the
number of smoothmuscle cells in the aorticmedia layer and fragmenta-
tion of the extracellular matrix of the aorta at the site of the aneurysms
because of inﬂammation, tissue remodeling and upregulation of matrix
metalloproteinases (MMPs) [21]. Ascending thoracic aneurysms are
characterized by medial necrosis, mucoid inﬁltration, cyst formation
with elastin degradation and vascular smooth muscle cell apoptosis
[19]. Although there are some differences in the pathobiology between
descending thoracic or abdominal aortic aneurysms and ascending
thoracic aneurysms, inﬂammatory response has an inﬂuence on the
formation of aortic aneurysms [22]. In the present study, the AA group
had a signiﬁcantly higher NL ratio and C-reactive protein level than
the control group. The result was conclusive evidence that the
inﬂammation exists in patients with aortic aneurysms and consistent
with results of previous studies [23]. On the other hand, the pathophys-
iology of CAE remains unclear. However, Virmani et al. had reported
that the main histological features of CAE were lipid deposition with
foam cells, ﬁbrous caps and extensive destruction of musculoelastic
elements of the media [24]. Additionally, several studies reported that
both abdominal aortic aneurysms and thoracic aortic aneurysms were
associated with CAE and shared common histological mechanisms to
develop aneurysms with CAE [5,6]. Same as aortic aneurysms, CAE has
atherosclerotic risk factors [1,10]. Although themechanism of aortic an-
eurysms and CAE is variable, patients with aortic aneurysms or CAE
demonstrated more pronounced inﬂammation [2,7–11]. The relation
between CAE and inﬂammatory markers in patients with aortic aneu-
rysms has not been reported. Regardless of the presence of aortic aneu-
rysms, CAE was associated with increased inﬂammatory markers such
as C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and
MMPs [8–11]. In addition, it was demonstrated that patients with CAE
had inﬁltration of the media layer by inﬂammatory cells in ectatic coro-
nary segments [7]. This may be related to the chronic inﬂammatory
response occurring in CAE. Furthermore, it was reported that CAE wasstrongly associated with the NL ratio [25]. This mechanism was that
neutrophils cause damage to the tissue and may play an important
role in CAE by secreting elastase, MMPs and oxygen free radicals [26,
27]. As a result of this chronic inﬂammatory response, coronary arterial
walls are weakened potentially resulting in CAE. In this study, the
CAE (+) group had a signiﬁcantly higher WBC level and NL ratio than
the CAE (−) group. It was suggested that the inﬂammatory response
was stronger in the CAE (+) group than in the CAE (−) group and
this may eventually lead to a high WBC level and NL ratio in the
CAE (+) group.
Patients with CAE present poor long-term cardiac outcomes [28].
CAE has been shown to decrease coronary ﬂow velocity [29]. In addi-
tion, the extent of CAE was correlated with coronary ﬂow velocity and
associated with a history of myocardial infarction independent of
coexisting signiﬁcant coronary stenosis [28]. And persistent slow coro-
nary blood ﬂow is associated with an increased risk of stent thrombosis
[30]. It was reported that preoperative NL ratio appears to be a signiﬁ-
cant predictor of both 30-day mortality and long-term outcome in
open aortic aneurysm surgery and myocardial infarction was the main
cause of perioperative mortality for aortic aneurysms [31]. For these
reasons, it has a clinical importance to assess NL ratio and detect CAE
in patients with aortic aneurysms in clinical decisions regarding man-
agement of these patients to avoid myocardial infarction and stent
thrombosis. Also, it was reported that ACE-I, ARB and statin reduced
MMPs and signiﬁcantly inhibited inﬁltration of macrophages into the
aortic wall, accompanied by a reduction of protein expression of
intercellular adhesion molecule-1 [32–34]. Because these drugs reduce
systemic inﬂammation, more use of these drugs would be an attractive
strategy asmedical treatment to prevent progression to CAE and cardio-
vascular event in patients with a high NL ratio before aortic aneurysm
surgery.5. Study limitations
Major limitation of this study is a small sample size. In addition, this
study is a retrospective analysis. Accurate assessment of coronary artery
stenosis may be difﬁcult in the presence of coronary ectasia due to
uncertainty in identifying the reference part of the vessel. Cytokines
related to inﬂammation were not investigated. We did not perform an
analysis of the prognostic value of the NL ratio in CAE. Although the
formation of aortic aneurysms and CAE is a slow, chronic condition,
we only evaluated a single NL ratio in this study.6. Conclusions
The presence of aortic aneurysms was associated with a higher inci-
dence of angiographic CAE and high NL ratio. Furthermore, the NL ratio
might predict the presence of CAE in patients with aortic aneurysms.
These ﬁndings suggested that CAE might need to be evaluated in pa-
tients with both aortic aneurysms and high NL ratio. Further studies
should be advocated to investigate the more clinical prognostic value
of NL ratio for patients with aortic aneurysms to reduce cardiovascular
event and long-term outcome of patients with both aortic aneurysms
and CAE with high NL ratio.Conﬂict of interest
None declared.Acknowledgments
None.
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